Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-03-27 00:00:00 ET · period of report 2024-03-26 · accession 0001415889-24-009205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-27 | 2024-03-26 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $10.97 | -2,114 | 40.9K | -5% | -$23.2K |
| D | 2024-03-27 | 2024-03-26 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.31 | +4,329 | 45.2K | +11% | +$10,000 |
| D | 2024-03-27 | 2024-03-26 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.31 | -4,329 | 183.0K | -2% | -$10,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-03-26 | S | D | 2,114 | $10.97 | 40,920 | D | — | — | (F1) Shares sold to satisfy tax obligation on option exercise. |
| 2 | Common | Common Shares | 2024-03-26 | M | A | 4,329 | $2.31 | 45,249 | D | — | — | (F2) Shares acquired through the exercise of an option pusuant to a 10b5-1 plan adopted on August 17, 2023. |
| 3 | Derivative | Common Shares | 2024-03-26 | M | D | 4,329 | $2.31 | 182,983 | D | $2.31 · 2014-04-24 to 2024-04-25 | 4,239 Options | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023. |